OverviewChartNewsTraderScreen

L&S Knock-Out Zealand Pharma A/S/  DE000LX4A6C2  /

EUWAX
2024-10-11  8:12:33 AM Chg.+0.10 Bid10:00:22 PM Ask10:00:22 PM Underlying Strike price Expiration date Option type
1.96EUR +5.38% -
Bid Size: -		 -
Ask Size: -		 - 89.8587 EUR 2078-12-31 Call
GlobeNewswire 08-22 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
GlobeNewswire 08-15 Zealand Pharma Announces Financial Results for the First Half of 2024
GlobeNewswire 08-12 Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial...
GlobeNewswire 07-29 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
GlobeNewswire 06-26 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire 06-25 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire 06-25 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire 06-20 Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...
GlobeNewswire 06-07 Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improveme...
GlobeNewswire 06-07 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...
GlobeNewswire 06-06 Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial ...
GlobeNewswire 05-31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 05-29 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
GlobeNewswire 05-23 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low ...
GlobeNewswire 05-16 Zealand Pharma Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05-09 Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...
GlobeNewswire 03-20 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatm...
GlobeNewswire 03-01 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
GlobeNewswire 02-27 Zealand Pharma Announces Financial Results for the Full Year 2023
TeleTrader 02-26 Zealand Pharma soars 30% on positive weight-loss drug results
GlobeNewswire 02-26 Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated ...
GlobeNewswire 02-26 Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver dise...
GlobeNewswire 02-20 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financia...
GlobeNewswire 01-19 Zealand Pharma major shareholder announcement: J O Hambro Capital Management
GlobeNewswire 01-17 Zealand Pharma major shareholder announcement: J O Hambro Capital Management